NVAX Earnings

Quarterly EPS
$-0.76
Q3 2024
$-0.51
Q4 2024
$3.22
Q1 2025
$0.66
Q2 2025
$-1.25
Q3 2025
$0.11
Q4 2025
$-0.06
Q1 2026
$-0.32
Q2 2026
Latest Revenue56.7M
Latest Net Income-53387000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.3256.7M-53387000-76.3%-148.5%
Q1 2026-$0.06139.5M-9491000-79.1%-101.9%
Q4 2025$0.11147.1M17.5M+66.6%+121.6%
Q3 2025-$1.2570.4M-202379000-16.6%-64.5%
Q2 2025$0.66239.2M106.5M-42.4%-39.4%
Q1 2025$3.22666.7M518.6M+610.3%+406.7%
Q4 2024-$0.5188.3M-81030000-69.7%+64.6%
Q3 2024-$0.7684.5M-121300000-54.8%+39.7%
Q2 2024$1.09415.5M162.4M
Q1 2024-$1.0593.9M-147550000
Q4 2023-$1.44291.3M-178389000
Q3 2023-$1.26187.0M-130776000
Novavax (NVAX) — Earnings